VJHemOnc Podcast The Lymphoma Sessions: highlights from EHA and ICML 2021
Jul 30, 2021
Guests including Gilles Salles, Nirav N. Shah, Ulrich Jäger, and Stephen Ansell discuss the latest updates in lymphoma from EHA and ICML 2021, highlighting antibody, cellular, and novel therapies. Topics covered include immune therapies, potential combinations of antibodies, challenges of implementing new therapy in community settings, novel BTK inhibitors, personalized treatment approaches, and advancements in lymphoma research and treatment.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 5min
Discussion on Potential Combinations of Antibodies for Lymphoma Treatment
05:02 • 5min
Challenges of Implementing New Therapy in Community Settings
10:18 • 27min
Novel BTK Inhibitor and Potential Targets in T-cell and Firmas
36:54 • 4min
Exploring Safety and Personalized Treatment Approaches for Lymphoma
40:51 • 2min
Advancements in Lymphoma Research and Treatment
43:17 • 6min